Cargando…
Safety of Therapeutic Apheresis in Children and Adolescents
BACKGROUND: Therapeutic apheresis (TA) is based on the principles of either removing dissolved pathogenic substances (e.g., antibodies) from the blood plasma or replacing plasma factors. It expands the therapeutic scope for a variety of diseases. Safety analysis in the pediatric field are scant. The...
Autores principales: | Taylan, Christina, Schaaf, Anne, Dorn, Corina, Schmitt, Claus Peter, Loos, Sebastian, Kanzelmeyer, Nele, Pape, Lars, Müller, Dominik, Weber, Lutz T., Thumfart, Julia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9039165/ https://www.ncbi.nlm.nih.gov/pubmed/35498796 http://dx.doi.org/10.3389/fped.2022.850819 |
Ejemplares similares
-
An update on lipid apheresis for familial hypercholesterolemia
por: Taylan, Christina, et al.
Publicado: (2022) -
Factors Associated With the Development of Chronic Kidney Disease in Children With Congenital Anomalies of the Kidney and Urinary Tract
por: Isert, Saskia, et al.
Publicado: (2020) -
Short- and Long-Term Renal Outcome of Hemolytic-Uremic Syndrome in Childhood
por: Vaterodt, Laura, et al.
Publicado: (2018) -
Case report: Early onset de novo FSGS in a child after kidney transplantation—a successful treatment
por: Carvajal Abreu, Karla, et al.
Publicado: (2023) -
Case Report: Exome Sequencing Reveals LRBA Deficiency in a Patient With End-Stage Renal Disease
por: Taylan, Christina, et al.
Publicado: (2020)